Product Information
PANTOPRAZOLE SOD DR 20 MG TAB is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.0426 per EA under NDC 82009001090. Its NADAC has been published 219 times since Jul 27, 2022.
FDA first approved this application on Sep 10, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Quallent Pharmaceuticals Health LLCNDC
82009001090
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PANTOPRAZOLE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA202882FDA Approved
9/10/2014
TE Code
AB
On Market Since
6/6/2022
Pharmacological Classes
Price Statistics
The NADAC for PANTOPRAZOLE SOD DR 20 MG TAB has been published 219 times since Jul 27, 2022, and over the history we have for it it has declined 15.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0426 per EA |
|---|---|
| All-time high | $0.0581 (Feb 15, 2023) |
| All-time low | $0.0367 (Nov 20, 2024) |
| 52-week high | $0.0469 |
| 52-week low | $0.0426 |
| Median price | $0.0476 |
| Average price | $0.0478 |
| Largest weekly change | -22.1% (Nov 20, 2024) |
| Weeks tracked | 219 |
| Tracking since | Jul 27, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Quallent Pharmaceuticals Health LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
PANTOPRAZOLE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PANTOPRAZOLE SOD DR 20 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for PANTOPRAZOLE SOD DR 20 MG TAB, manufactured by Quallent Pharmaceuticals Health LLC, is $0.0426 per EA (NDC 82009001090), effective Sep 30, 2026.
How has the price of PANTOPRAZOLE SOD DR 20 MG TAB changed over time?
Over the history we have for it, the NADAC for PANTOPRAZOLE SOD DR 20 MG TAB has declined 15.2%. It has been tracked across 219 weekly CMS publications since Jul 27, 2022.
What are the highest and lowest recorded NADAC prices for PANTOPRAZOLE SOD DR 20 MG TAB?
Since Jul 27, 2022, the NADAC for PANTOPRAZOLE SOD DR 20 MG TAB has ranged from a low of $0.0367 (Nov 20, 2024) to a high of $0.0581 (Feb 15, 2023), with a median of $0.0476 per EA.
Are there cheaper alternatives to PANTOPRAZOLE SOD DR 20 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PANTOPRAZOLE SOD DR 20 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures PANTOPRAZOLE SOD DR 20 MG TAB?
PANTOPRAZOLE SOD DR 20 MG TAB (NDC 82009001090) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.